Skip to main content
Top

Clinical and Translational Oncology

Issue 12/2012

Content (12 Articles)

Editorial

Depicting the evolving scenario of translational-guided drug development

G. Argilés, J. Rodon, J. Tabernero

Educational Series – Blue Series

Therapeutic nanosystems for oncology nanomedicine

A. S. Gonçalves, A. S. Macedo, E. B. Souto

Educational Series – Red Series*

Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy

Diego Marquez-Medina, Joel Salla-Fortuny, Antonieta Salud-Salvia

Research Article

Characteristics and long-term survival of colorectal cancer patients aged 44 years and younger

Zuli Yang, Liang Kang, Lei Wang, Jun Xiang, Guanfu Cai, Ji Cui, Junsheng Peng, Ping Lan, Jianping Wang

Research Article

Helicobacter pylori infection of the larynx may be an emerging risk factor for laryngeal squamous cell carcinoma

Hongli Gong, Yi Shi, Liang Zhou, Lei Tao, Yong Shi, Wenjun Cao, Lei Cheng

Research Article

Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer

Bala Basak Oven Ustaalioglu, Ahmet Bilici, Nagehan Ozdemir Barisik, Mehmet Aliustaoglu, Fugen Aker Vardar, Burcak Erkol Yilmaz, Mesut Seker, Mahmut Gumus

Research Article

Intraperitoneal bevacizumab combined with cytoreductive surgery: a pre-clinical study of tolerance and pharmacokinetics in an animal model

Guillaume Passot, Aurélien Dupré, Michel Rivoire, Faheez Mohamed, Naoual Bakrin, Olivier Glehen

Research Article

Study of KRAS new predictive marker in a clinical laboratory

Inmaculada Bando, Lourdes Cillero, Julián Sanz-Ortega, Patricia Llovet, Paula Pescador, Milagros Ferrer, Miguel de la Hoya, Javier Sastre, Eduardo Díaz-Rubio García, Trinidad Caldés

Research Article

Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy

Dongqing Wang, Jingyu Zhu, Jinbo Sun, Baosheng Li, Zhongtang Wang, Ling Wei, Yong Yin, Hongfu Sun, Zheng Fu, Xingguo Zhang, Zongwei Huo

Review Article

Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: long-term toxicity and esthetic assessment

Aurora Rodríguez Pérez, Maria Concepción López Carrizosa, Pilar Maria Samper Ots, José Fermín Pérez-Regadera Gómez, José Zapatero Ortuño, Juan de Dios Sáez Garrido, Manuel Joaquín Martín de Miguel

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine